Metraipolis › archive › dc_dc47deb4a2b0

Dopaminergic nigrostriatal vulnerability in Parkinson's Disease with diabetes: evidence from severity-matched cohorts — Europe PMC PMID:42321543

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42321543
DOI
10.1007/s00259-[numero omesso]-0
License (as archived)
solo-consultazione
Archived
2026-10-07T11:54:38.929Z
SHA-256 of the archived text
286eec629d70344465ec7951b88c916f7b513df1e27a8307c7ea064aab381b10
Stable URL of this page
https://metraipolis.com/documento/dc_dc47deb4a2b0

How to cite

Dopaminergic nigrostriatal vulnerability in Parkinson's Disease with diabetes: evidence from severity-matched cohorts — Europe PMC PMID:42321543 — Europe PMC (en), https://europepmc.org/article/MED/42321543 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_dc47deb4a2b0 (Metraipolis archive dc_dc47deb4a2b0, sha256 286eec629d70344465ec7951b88c916f7b513df1e27a8307c7ea064aab381b10)
BibTeX
@misc{dcdc47deb4a2b0,
  title = {Dopaminergic nigrostriatal vulnerability in Parkinson's Disease with diabetes: evidence from severity-matched cohorts — Europe PMC PMID:42321543},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42321543},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_dc47deb4a2b0; sha256 286eec629d70344465ec7951b88c916f7b513df1e27a8307c7ea064aab381b10},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42321543. Agents can read the archived copy with the MCP tool read_document.